Drug Markets/Vericiguat

Vericiguat

9 NDCs across 1 manufacturer|0 Generic,9 Brand

▸ More about this market

The brand product was first FDA-approved on Jan 19, 2021. In 2024, Medicare Part D spent $50 million on Vericiguat across 50,000 claims for 11,000 beneficiaries.

Vericiguat is available as 9 NDCs from 1 manufacturer (0 generic, 9 brand), with NADAC prices from $22.72 to $22.73 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

9

0G / 9B

Manufacturers

1

competing in market

Price Spread

$22.72 – $22.73

per EA

7d Activity

6↑3↓0 flat

avg -0.0% WoW · of 9 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Frequently Asked Questions

How much does Medicare spend on Vericiguat?

In 2024, Medicare Part D spent $50 million on Vericiguat across 50,000 claims for 11,000 beneficiaries.

How many Vericiguat products are on the market?

The Vericiguat drug market contains 9 NDCs from 1 manufacturer — 0 generic and 9 brand products.

What is the price range for Vericiguat?

NADAC reference prices for Vericiguat range from $22.7248 to $22.7269 per EA — a 0% difference between cheapest and most expensive.

Which manufacturers make Vericiguat?

1 manufacturer lists Vericiguat in NADAC. Ranked by number of NDCs, the largest are Merck Sharp & Dohme LLC (9).

How has the price of Vericiguat changed recently?

Over the past 7 days, 6 Vericiguat NDCs rose and 3 fell, with a market-wide average change of -0.0%.